Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soko Setoguchi

Showing results (41-50 of 188) with videos related to

Pageof 19
Sort By:
Cardiovascular Diabetology|March 10, 2023
Cardiovascular outcomes with SGLT2 inhibitors versus DPP4 inhibitors and GLP-1 receptor agonists in patients with heart failure with reduced and preserved ejection fractionJimmy Gonzalez, Benjamin A Bates, Soko Setoguchi, et al.
Journal of Clinical Epidemiology|March 3, 2016
Comparison of high-dimensional confounder summary scores in comparative studies of newly marketed medicationsHiraku Kumamaru, Joshua J Gagne, Robert J Glynn, et al.
CNS Drugs|January 29, 2009
Assessing residual confounding of the association between antipsychotic medications and risk of death using survey dataSebastian Schneeweiss, Soko Setoguchi, M Alan Brookhart, et al.
The American Journal of Cardiology|August 9, 2022
Relation of Sociodemographic Factors With Primary Cause of Hospitalization Among Patients With Left Ventricular Assist Devices (from the National Inpatient Sample 2012 to 2017)Janet Cai, Weiyi Xia, Patricia Greenberg, et al.
Emerging Themes in Epidemiology|April 8, 2016
Dimension reduction and shrinkage methods for high dimensional disease risk scores in historical dataHiraku Kumamaru, Sebastian Schneeweiss, Robert J Glynn, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 18, 2009
Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failureSoko Setoguchi, Anju Nohria, Jeremy A Rassen, et al.
American Heart Journal|March 10, 2010
Propranolol and the risk of hospitalized myopathy: translating chemical genomics findings into population-level hypothesesSoko Setoguchi, John M Higgins, Helen Mogun, et al.
The American Journal of Cardiology|September 22, 2007
Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of ageSoko Setoguchi, Robert J Glynn, Jerry Avorn, et al.
Arthritis Care & Research|November 1, 2012
Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsiaKristin Palmsten, Sonia Hernández-Díaz, Bindee Kuriya, et al.
Pharmacoepidemiology and Drug Safety|October 29, 2008
Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patientsNiteesh K Choudhry, Soko Setoguchi, Raisa Levin, et al.
Pageof 19

Showing results (41-50 of 188) with videos related to

Sort By:
Pageof 19
Cardiovascular Diabetology|March 10, 2023
Cardiovascular outcomes with SGLT2 inhibitors versus DPP4 inhibitors and GLP-1 receptor agonists in patients with heart failure with reduced and preserved ejection fractionJimmy Gonzalez, Benjamin A Bates, Soko Setoguchi, et al.
Journal of Clinical Epidemiology|March 3, 2016
Comparison of high-dimensional confounder summary scores in comparative studies of newly marketed medicationsHiraku Kumamaru, Joshua J Gagne, Robert J Glynn, et al.
CNS Drugs|January 29, 2009
Assessing residual confounding of the association between antipsychotic medications and risk of death using survey dataSebastian Schneeweiss, Soko Setoguchi, M Alan Brookhart, et al.
The American Journal of Cardiology|August 9, 2022
Relation of Sociodemographic Factors With Primary Cause of Hospitalization Among Patients With Left Ventricular Assist Devices (from the National Inpatient Sample 2012 to 2017)Janet Cai, Weiyi Xia, Patricia Greenberg, et al.
Emerging Themes in Epidemiology|April 8, 2016
Dimension reduction and shrinkage methods for high dimensional disease risk scores in historical dataHiraku Kumamaru, Sebastian Schneeweiss, Robert J Glynn, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 18, 2009
Maximum potential benefit of implantable defibrillators in preventing sudden death after hospital admission because of heart failureSoko Setoguchi, Anju Nohria, Jeremy A Rassen, et al.
American Heart Journal|March 10, 2010
Propranolol and the risk of hospitalized myopathy: translating chemical genomics findings into population-level hypothesesSoko Setoguchi, John M Higgins, Helen Mogun, et al.
The American Journal of Cardiology|September 22, 2007
Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of ageSoko Setoguchi, Robert J Glynn, Jerry Avorn, et al.
Arthritis Care & Research|November 1, 2012
Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsiaKristin Palmsten, Sonia Hernández-Díaz, Bindee Kuriya, et al.
Pharmacoepidemiology and Drug Safety|October 29, 2008
Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patientsNiteesh K Choudhry, Soko Setoguchi, Raisa Levin, et al.
Pageof 19